Boston Scientific Corp. agreed to buy the American Medical Systems urology portfolio from Endo International Plc for at least $1.6 billion in cash to expand in men’s health and prostate treatments.

The purchase includes a potential additional $50 million milestone based on 2016 sales, Boston Scientific said in a statement on Monday. The businesses will become part of the Marlborough, Massachusetts-based company’s urology and women’s health arm.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.